home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Cell-Cycle Restriction Helps Leukaemia Stem Cells Keep Going

  January, 13 2009 18:25
your information resource in human molecular genetics

A protein that aids the survival of cancer-causing stem cells is described in Nature. The study boosts our understanding of leukaemia and may help the development of new anti-cancer therapies.

Leukaemias are fuelled by rogue cancer stem cells that can divide asymmetrically to produce more cancer stem cells and other more specialized cancerous cells. Pier Giuseppe Pelicci and colleagues show that leukaemia-associated oncogenes trigger DNA damage in blood stem cells. The cell cycle inhibitor p21 is then upregulated, temporarily preventing the cancer stem cells from proliferating and giving them time to repair the damage. This means the same cancer stem cells can, in theory, go on to reseed the cancer.

Most cancer therapies focus on killing rapidly dividing cancer cells, and are not designed to kill any quiescent or slowly dividing cancer stem cells that may exist. The study indicates that p21 could be a viable anti-cancer target. If the p21-dependent DNA repair is blocked, the slowly proliferating leukaemia stem cells should eventually become exhausted and die.


Pier Giuseppe Pelicci (Istituto Europeo di Oncologia, Milan, Italy)
E-mail: piergiuseppe.pelicci@ifom-ieo-campus.it

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.